SK E&S has collaborated with global partners to establish foundation for the domestic low-carbon hydrogen* industry, with support from local government. They plan to mass-produce low-carbon hydrogen, leading the early establishment of the domestic hydrogen ecosystem and contributing to global carbon neutrality.
SK pharmteco will participate at the CPHI 2023 in Barcelona and prepare a dedicated booth at the event. As a multi-modality CDMO with expertise in small molecule active pharmaceutical ingredients (APIs) and biopharmaceuticals, SK pharmteco aims to present its business competitiveness and actively pursue business opportunities.